Reuters logo
BRIEF-Summit Therapeutics announces pricing of public offering $12.00 per ADS
September 14, 2017 / 3:29 AM / in 2 months

BRIEF-Summit Therapeutics announces pricing of public offering $12.00 per ADS

Sept 14 (Reuters) - Summit Therapeutics Plc-

* Summit Therapeutics announces pricing of public offering of 1,459,000 American Depositary Shares

* Announces pricing of underwritten public offering of 1.45 mln American Depositary Shares at a price of $12.00 per ADS Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below